Dashenlin Pharm Grp Co Ltd Capital Reinvestment Ratio
Dashenlin Pharm Grp Co Ltd capital reinvestment ratio. Dashenlin Pharm Grp Co Ltd (603233) has a Capital Reinvestment Ratio of 0.20x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥818.72 Million) in capital expenditures (CN¥161.42 Million). Check Dashenlin Pharm Grp Co Ltd (603233) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Dashenlin Pharm Grp Co Ltd (2012–2025)
Capital reinvestment ratio of Dashenlin Pharm Grp Co Ltd from 2012 to 2025. This chart tracks Dashenlin Pharm Grp Co Ltd's Capital Reinvestment Ratio across 14 annual periods. Also explore how fast is Dashenlin Pharm Grp Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Dashenlin Pharm Grp Co Ltd Capital Reinvestment Ratio by Year (2012–2025)
Dashenlin Pharm Grp Co Ltd capital reinvestment ratio by year from 2012 to 2025. For the full cash flow conversion analysis, see how efficiently does Dashenlin Pharm Grp Co Ltd generate cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥5.35 Billion | CN¥484.84 Million | ▼ -80.9% |
| 2024 | 0.48x | CN¥3.11 Billion | CN¥1.48 Billion | ▼ -16.1% |
| 2023 | 0.57x | CN¥3.17 Billion | CN¥1.80 Billion | ▲ +105.5% |
| 2022 | 0.28x | CN¥3.76 Billion | CN¥1.03 Billion | ▼ -66.9% |
| 2021 | 0.83x | CN¥1.55 Billion | CN¥1.29 Billion | ▲ +105.4% |
| 2020 | 0.41x | CN¥1.95 Billion | CN¥792.32 Million | ▲ +38.1% |
| 2019 | 0.29x | CN¥1.71 Billion | CN¥501.41 Million | ▼ -53.7% |
| 2018 | 0.63x | CN¥873.64 Million | CN¥554.39 Million | ▼ -39.2% |
| 2017 | 1.04x | CN¥640.39 Million | CN¥668.53 Million | ▲ +68.3% |
| 2016 | 0.62x | CN¥495.60 Million | CN¥307.35 Million | ▲ +17.3% |
| 2015 | 0.53x | CN¥468.59 Million | CN¥247.84 Million | ▼ -9.4% |
| 2014 | 0.58x | CN¥448.58 Million | CN¥261.82 Million | ▼ -53.8% |
| 2013 | 1.26x | CN¥288.22 Million | CN¥363.99 Million | ▲ +510.4% |
| 2012 | 0.21x | CN¥289.31 Million | CN¥59.85 Million | — |